Galectin-1 couples glycobiology to inflammation in osteoarthritis through the activation of an NF-κB-regulated gene network

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1910-1921

  Toegel, Stefan ^a   Weinmann, Daniela ^a   André, Sabine ^b   Walzer, Sonja M ^a   Bilban, Martin ^a   Schmidt, Sebastian ^b   Chiari, Catharina ^a   Windhager, Reinhard ^a   Krall, Christoph ^a   Bennani Baiti, Idriss M ^c   Gabius, Hans Joachim ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c B2 Scientific Group   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICULAR CARTILAGE; CARTILAGE CELL; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; GLYCOBIOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CHONDROCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALECTIN 1; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLYCOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84958580918     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501165     Document Type: Article

References (58)

1. Glyn-Jones, S., A. J. R. Palmer, R. Agricola, A. J. Price, T. L. Vincent, H. Weinans, and A. J. Carr. 2015. Osteoarthritis. Lancet 386: 376-387.
2. Centers for Disease Control and Prevention Public Health Service U. S. Department of Health and Human Services. 2010. Osteoarthritis and you: patient information from the CDC. J. Pain Palliat. Care Pharmacother. 24: 430-431.
3. Gabius, H.-J. 2015. The magic of the sugar code. Trends Biochem. Sci. 40: 341.
4. Solís, D., N. V. Bovin, A. P. Davis, J. Jiménez-Barbero, A. Romero, R. Roy, K. Smetana, Jr., and H.-J. Gabius. 2015. A guide into glycosciences: how chemistry, biochemistry and biology cooperate to crack the sugar code. Biochim. Biophys. Acta 1850: 186-235.
5. Kaltner, H., and H.-J. Gabius. 2012. A toolbox of lectins for translating the sugar code: The galectin network in phylogenesis and tumors. Histol. Histopathol. 27: 397-416.
6. Liu, F.-T., R.-Y. Yang, and D. K. Hsu. 2012. Galectins in acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1253: 80-91.
7. Smetana, K., Jr., S. André, H. Kaltner, J. Kopitz, and H.-J. Gabius. 2013. Context-dependent multifunctionality of galectin-1: A challenge for defining the lectin as therapeutic target. Expert Opin. Ther. Targets 17: 379-392.
8. Toegel, S., M. Pabst, S. Q. Wu, J. Grass, M. B. Goldring, C. Chiari, A. Kolb, F. Altmann, H. Viernstein, and F. M. Unger. 2010. Phenotype-related differential a-2,6-or a-2,3-sialylation of glycoprotein N-glycans in human chondrocytes. Osteoarthritis Cartilage 18: 240-248.
9. Toegel, S., D. Bieder, S. André, F. Altmann, S. M. Walzer, H. Kaltner, J. G. Hofstaetter, R. Windhager, and H.-J. Gabius. 2013. Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein. Arthritis Res. Ther. 15: R147.
10. Toegel, S., D. Bieder, S. André, K. Kayser, S. M. Walzer, G. Hobusch, R. Windhager, and H.-J. Gabius. 2014. Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration. Histochem. Cell Biol. 142: 373-388.
11. Gomez-Brouchet, A., F. Mourcin, P.-A. Gourraud, C. Bouvier, G. De Pinieux, S. Le Guelec, P. Brousset, M.-B. Delisle, and C. Schiff. 2010. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Hum. Pathol. 41: 1220-1230.
12. Marcon, P., E. Marsich, A. Vetere, P. Mozetic, C. Campa, I. Donati, F. Vittur, A. Gamini, and S. Paoletti. 2005. The role of Galectin-1 in the interaction between chondrocytes and a lactose-modified chitosan. Biomaterials 26: 4975-4984.
13. Marsich, E., P. Mozetic, F. Ortolani, M. Contin, M. Marchini, A. Vetere, S. Pacor, S. Semeraro, F. Vittur, and S. Paoletti. 2008. Galectin-1 in cartilage: expression, influence on chondrocyte growth and interaction with ECM components. Matrix Biol. 27: 513-525.
14. Zhou, Q., and R. D. Cummings. 1993. L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch. Biochem. Biophys. 300: 6-17.
15. André, S., S. Kojima, N. Yamazaki, C. Fink, H. Kaltner, K. Kayser, and H.-J. Gabius. 1999. Galectins-1 and-3 and their ligands in tumor biology: non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J. Cancer Res. Clin. Oncol. 125: 461-474.
16. Jing, L., S. So, S. W. Lim, W. J. Richardson, R. D. Fitch, L. A. Setton, and J. Chen. 2012. Differential expression of galectin-1 and its interactions with cells and laminins in the intervertebral disc. J. Orthop. Res. 30: 1923-1931.
17. Li, S., Y. Yu, C. D. Koehn, Z. Zhang, and K. Su. 2013. Galectins in the pathogenesis of rheumatoid arthritis. J. Clin. Cell. Immunol. 4: 1000164.
18. Ahmed, T. J., M. K. Kaneva, C. Pitzalis, D. Cooper, and M. Perretti. 2014. Resolution of inflammation: examples of peptidergic players and pathways. Drug Discov. Today 19: 1166-1171.
19. Ohshima, S., S. Kuchen, C. A. Seemayer, D. Kyburz, A. Hirt, S. Klinzing, B. A. Michel, R. E. Gay, F.-T. Liu, S. Gay, and M. Neidhart. 2003. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48: 2788-2795.
20. Neidhart, M., C. A. Seemayer, K. M. Hummel, B. A. Michel, R. E. Gay, and S. Gay. 2003. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheum. 48: 1873-1880.
21. Dasuri, K., M. Antonovici, K. Chen, K.Wong, K. Standing,W. Ens, H. El-Gabalawy, and J. A. Wilkins. 2004. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res. Ther. 6: R161-R168.
22. Xibillé-Friedmann, D., C. Bustos Rivera-Bahena, J. Rojas-Serrano, R. Burgos-Vargas, and J.-L. Montiel-Hernández. 2013. A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis. Scand. J. Rheumatol. 42: 102-107.
23. Sarter, K., C. Janko, S. André, L. E. Munõz, C. Schorn, S. Winkler, J. Rech, H. Kaltner, H. M. Lorenz, M. Schiller, et al. 2013. Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus. Glycobiology 23: 12-22.
24. Iqbal, A. J., D. Cooper, A. Vugler, B. R. Gittens, A. Moore, and M. Perretti. 2013. Endogenous galectin-1 exerts tonic inhibition on experimental arthritis. J. Immunol. 191: 171-177.
25. Kaltner, H., K. Seyrek, A. Heck, F. Sinowatz, and H.-J. Gabius. 2002. Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts: comparison of cell type-specific expression profiles and subcellular localization. Cell Tissue Res. 307: 35-46.
26. Sarter, K., S. André, H. Kaltner, M. Lensch, C. Schulze, V. Urbonaviciute, G. Schett, M. Herrmann, and H.-J. Gabius. 2009. Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins. Biochem. Biophys. Res. Commun. 379: 155-159.
27. André, S., H. Sanchez-Ruderisch, H. Nakagawa, M. Buchholz, J. Kopitz, P. Forberich, W. Kemmner, C. Böck, K. Deguchi, K. M. Detjen, et al. 2007. Tumor suppressor p16INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274: 3233-3256.
28. Amano, M., H. Eriksson, J. C. Manning, K. M. Detjen, S. André, S. Nishimura, J. Lehtiö, and H.-J. Gabius. 2012. Tumour suppressor p16INK4a: anoikisfavouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. FEBS J. 279: 4062-4080.
29. Toegel, S., V. E. Plattner, S. Q. Wu, M. B. Goldring, C. Chiari, A. Kolb, F. M. Unger, S. Nehrer, F. Gabor, H. Viernstein, and M. Wirth. 2009. Lectin binding patterns reflect the phenotypic status of in vitro chondrocyte models. In Vitro Cell. Dev. Biol. Anim. 45: 351-360.
30. Toegel, S., S. Q. Wu, M. Otero, M. B. Goldring, P. Leelapornpisid, C. Chiari, A. Kolb, F. M. Unger, R. Windhager, and H. Viernstein. 2012. Caesalpinia sappan extract inhibits IL1b-mediated overexpression of matrix metalloproteinases in human chondrocytes. Genes Nutr. 7: 307-318.
31. Bustin, S. A., J.-F. Beaulieu, J. Huggett, R. Jaggi, F. S. Kibenge, P. A. Olsvik, L. C. Penning, and S. Toegel. 2010. MIQE précis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol. Biol. 11: 74.
32. Ramadoss, P., B. J. Abraham, L. Tsai, Y. Zhou, R. H. Costa-e-Sousa, F. Ye, M. Bilban, K. Zhao, and A. N. Hollenberg. 2014. Novel mechanism of positive versus negative regulation by thyroid hormone receptor b1 (TRb1) identified by genome-wide profiling of binding sites in mouse liver. J. Biol. Chem. 289: 1313-1328.
33. Bennani-Baiti, I. M., D. N. Aryee, J. Ban, I. Machado, M. Kauer, K. Muhlbacher, G. Amann, A. Llombart-Bosch, and H. Kovar. 2011. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J. Pathol. 225: 353-363.
34. Bennani-Baiti, I. M., A. Cooper, E. R. Lawlor, M. Kauer, J. Ban, D. N. T. Aryee, and H. Kovar. 2010. Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma. Clin. Cancer Res. 16: 3769-3778.
35. Kaltner, H., A. S. Raschta, J. C. Manning, and H.-J. Gabius. Copy-number variation of functional galectin genes: studying animal galectin-7 (p53-induced gene 1 in man) and tandem-repeat-type galectins-4 and-9. Glycobiology 23: 1152-1163.
36. Bennani-Baiti, B., and I. M. Bennani-Baiti. 2012. Gene symbol precision. Gene 491: 103-109.
37. Toscano, M. A., L. Campagna, L. L. Molinero, J. P. Cerliani, D. O. Croci, J. M. Ilarregui, M. B. Fuertes, I. M. Nojek, J. P. Fededa, N. W. Zwirner, et al. 2011. Nuclear factor (NF)-kB controls expression of the immunoregulatory glycan-binding protein galectin-1. Mol. Immunol. 48: 1940-1949.
38. Sellam, J., and F. Berenbaum. 2010. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6: 625-635.
39. Troeberg, L., and H. Nagase. 2012. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim. Biophys. Acta 1824: 133-145.
40. Marcu, K. B., M. Otero, E. Olivotto, R. M. Borzi, and M. B. Goldring. 2010. NFkB signaling: multiple angles to target OA. Curr. Drug Targets 11: 599-613.
41. Tetlow, L. C., D. J. Adlam, and D. E. Woolley. 2001. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 44: 585-594.
42. Wang, Y.-G., S.-J. Kim, J.-H. Baek, H.-W. Lee, S.-Y. Jeong, and K.-H. Chun. 2012. Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression. Exp. Mol. Med. 44: 387-393.
43. Dange, M. C., N. Srinivasan, S. K. More, S. M. Bane, A. Upadhya, A. D. Ingle, R. P. Gude, R. Mukhopadhyaya, and R. D. Kalraiya. 2014. Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells. Clin. Exp. Metastasis 31: 661-673.
44. Mauris, J., A. M. Woodward, Z. Cao, N. Panjwani, and P. Argueso. 2014. Molecular basis for MMP9 induction and disruption of epithelial cell-cell contacts by galectin-3. J. Cell Sci. 127: 3141-3148.
45. Demers, M., T. Magnaldo, and Y. St-Pierre. 2005. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res. 65: 5205-5210.
46. Saussez, S., S. Cludts, A. Capouillez, G. Mortuaire, K. Smetana, Jr., H. Kaltner, S. André, X. Leroy, H.-J. Gabius, and C. Decaestecker. 2009. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and-7. Int. J. Oncol. 34: 433-439.
47. Sana, T. R., M. J. Janatpour, M. Sathe, L. M. McEvoy, and T. K. McClanahan. 2005. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29: 256-269.
48. Tian, B., D. E. Nowak, M. Jamaluddin, S. Wang, and A. R. Brasier. 2005. Identification of direct genomic targets downstream of the nuclear factor-kB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280: 17435-17448.
49. Satelli, A., and U. S. Rao. 2011. Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett. 301: 38-46.
50. Yun, S. P., S.-J. Lee, Y. H. Jung, and H. J. Han. 2014. Galectin-1 stimulates motility of human umbilical cord blood-derived mesenchymal stem cells by downregulation of smad2/3-dependent collagen 3/5 and upregulation of NF-kBdependent fibronectin/laminin 5 expression. Cell Death Dis. 5: e1049.
51. Fitzner, B., H. Walzel, G. Sparmann, J. Emmrich, S. Liebe, and R. Jaster. 2005. Galectin-1 is an inductor of pancreatic stellate cell activation. Cell. Signal. 17: 1240-1247.
52. Masamune, A., M. Satoh, J. Hirabayashi, K. Kasai, K. Satoh, and T. Shimosegawa. 2006. Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G729-G736.
53. Valach, J., Z. Fík, H. Strnad, M. Chovanec, J. Plzák, Z. Cada, P. Szabo, J. Sáchová, M. Hroudová, M. Urbanová, et al. 2012. Smooth muscle actinexpressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors. Int. J. Cancer 131: 2499-2508.
54. Leijten, J. C. H., J. Emons, C. Sticht, S. van Gool, E. Decker, A. Uitterlinden, G. Rappold, A. Hofman, F. Rivadeneira, S. Scherjon, et al. 2012. Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum. 64: 3302-3312.
55. van der Kraan, P. M., and W. B. van den Berg. 2012. Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 20: 223-232.
56. Gabius, H.-J., H. Kaltner, J. Kopitz, and S. André. 2015. The glycobiology of the CD system: A dictionary for translating marker designations into glycan/lectin structure and function. Trends Biochem. Sci. 40: 360-376.
57. Sanchez-Ruderisch, H., C. Fischer, K. M. Detjen, M. Welzel, A. Wimmel, J. C. Manning, S. André, and H.-J. Gabius. 2010. Tumor suppressor p16 INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 277: 3552-3563.
58. Koh, H. S., C. Lee, K. S. Lee, C. S. Ham, R. H. Seong, S. S. Kim, and S. H. Jeon. 2008. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kB upon T-cell activation. Biochem. Biophys. Res. Commun. 370: 149-153.